Nursing management of the nonhospitalized patient receiving recombinant interleukin-2.
Clinical trials have demonstrated that rIL-2 can be safely administered in an outpatient setting. A thorough nursing assessment ensures patient safety and effective toxicity management. Because it is becoming more economically advantageous to treat patients on an outpatient basis, nurses will need to become involved in all aspects of managed care. Outpatient administration of rIL-2 challenges nurses to be both technologically expert and clinically proficient.